July 6, 2026

Daily Update: Key Developments in Sports, International Affairs, and Health Proposals

Sports: Folarin Balogun’s Red Card Suspension Overturned

United States striker, Folarin Balogun, has been reinstated for the team’s round-of-16 match against Belgium after FIFA overturned his suspension. Balogun received a red card for inadvertently stepping on Bosnia-Herzegovina’s Tarik Muharemović’s leg during a previous match. President Donald Trump allegedly contacted FIFA President Gianni Infantino, urging him to reconsider the suspension, though FIFA has not confirmed if the call influenced their decision. Trump expressed gratitude to FIFA for rectifying what he called a ‘great injustice.’

However, Belgium’s soccer federation expressed dissatisfaction, citing FIFA’s disciplinary code that mandates a suspension following a red card. Belgium argued that the ruling contradicted tournament regulations.

What You Missed: England overcame Mexico in a dramatic match at Azteca Stadium, advancing despite losing Jarell Quansah to a red card. Brazil faced elimination by Norway, as Erling Haaland shone with another brace.

What to Watch: The Iberian Clásico between Portugal and Spain begins at 3 p.m. ET, followed by the U.S. versus Belgium at 8 p.m.

Iran: Mourning Late Supreme Leader Ali Khamenei

Iran marks the third day of mourning for late Supreme Leader Ayatollah Ali Khamenei with a procession in Tehran. The event features his flag-draped coffin and those of family members killed at the onset of war. Massive crowds joined the funeral procession, demanding revenge on the U.S. and Israel. Effigies, including one of Trump being hanged, were visible along the route.

The mourning continues tomorrow in Qom, with daily life temporarily suspended to honor the late leader. Notably absent was current Supreme Leader Mojtaba Khamenei from the ceremonies.

Health: Testosterone Therapy Proposal

The Department of Health and Human Services has suggested relaxing restrictions on testosterone replacement therapy. Evidence suggests this hormone doesn’t increase heart disease or prostate cancer risks. This follows an FDA advisory panel’s support for TRT among men with low testosterone levels.

Dr. Helen L. Bernie notes TRT should only be prescribed for specific medical conditions, as the hormone naturally declines with age. However, the FDA proposal includes restrictions regarding candidates for therapy.

TAGS: